sorry to hear your loss, I bought in at around February and averaged down in March, was at break even point at $9.55, but didn't sell a single cent, im ok with a big sudden drop, but bleeding 1% everyday is indeed frustrating, like I've only been holding for 2 months, imagine people holding for the past 8 months, I completely understand why you've sold out, but why sell now when it is clearly oversold imo.
I just want to give some calculations for people reading this, At 1H21 670m estimate and FY21 1.4-1.55B estimate, we stayed around $10 mark, and after last report, we have 677m 1H21 result and FY21 at estimate down to lower end 1.4b, a better than estimate 1H21 and a minor downgrade for FY21, but let's assume we stay 677m for the next half with daigou channel resuming at a similar pace, we will have revenue of 1.354B, this I think is the worst case scenario for A2M in terms of daigou channel, especially with vaccine rolling out, so it's another < 5% downgrade from the 1.4B, at 1.4B estimate we opened at $9 and reached lowest $8.33, taking into consideration the 5% for worst case scenario of revenue 1.354B, we have $8.33 - the 5% for worst case = $7.92. so anything below $7.92 is a bargin, and it's going to recover from here without anything else disrupting the business, if it continues to go down, it is illogical and I think someone is playing games.
- Forums
- ASX - By Stock
- A2M
- Chart Update
Chart Update, page-17851
-
- There are more pages in this discussion • 7,380 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.85 |
Change
-0.030(0.44%) |
Mkt cap ! $4.952B |
Open | High | Low | Value | Volume |
$6.93 | $6.98 | $6.83 | $10.27M | 1.490M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 18844 | $6.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.85 | 41602 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 11039 | 6.840 |
1 | 3000 | 6.830 |
4 | 17920 | 6.820 |
4 | 9541 | 6.810 |
2 | 5020 | 6.800 |
Price($) | Vol. | No. |
---|---|---|
6.850 | 41602 | 1 |
6.860 | 548 | 1 |
6.870 | 8050 | 3 |
6.880 | 16820 | 3 |
6.890 | 5115 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online